Glucagon-like peptide 1 receptor agonists in internal medicine and general practice: from diabetes to the cardio-renal-metabolic syndrome
Cahiers Santé Médecine Thérapeutique · 2026-10 · 35 (5) · 376-381
DOI: 10.1684/sanmt.2026.430 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cahiers Santé Médecine Thérapeutique, 2026-10. Verfasst von Emmanuel Andrès und 1 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Andrès, E., & Lorenzo-Villalba, N. (2026). Glucagon-like peptide 1 receptor agonists in internal medicine and general practice: from diabetes to the cardio-renal-metabolic syndrome. Cahiers Santé Médecine Thérapeutique, 35(5), 376-381. https://doi.org/10.1684/sanmt.2026.430
Vancouver
Andrès E, Lorenzo-Villalba N. Glucagon-like peptide 1 receptor agonists in internal medicine and general practice: from diabetes to the cardio-renal-metabolic syndrome. Cahiers Santé Médecine Thérapeutique. 2026;35(5):376-381. doi:10.1684/sanmt.2026.430
BibTeX
@article{Andrs2026,
author = {Andrès, Emmanuel and Lorenzo-Villalba, Noel},
title = {Glucagon-like peptide 1 receptor agonists in internal medicine and general practice: from diabetes to the cardio-renal-metabolic syndrome},
journal = {Cahiers Santé Médecine Thérapeutique},
year = {2026},
volume = {35},
number = {5},
pages = {376--381},
doi = {10.1684/sanmt.2026.430}
}
EUVIMED